{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:14:03Z","timestamp":1788362043707,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170350"],"award-info":[{"award-number":["82170350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170363"],"award-info":[{"award-number":["82170363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bbadis.2023.166979","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T01:19:17Z","timestamp":1701911957000},"page":"166979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"1870","author":[{"given":"Guang-Feng","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.bbadis.2023.166979_bb0005","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonz\u00e1lez","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166979_bb0010","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910865","article-title":"Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?","volume":"12","author":"Sweeney","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166979_bb0015","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166979_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0025","first-page":"14","article-title":"Cardiosphere-derived cells reverse heart failure with preserved ejection fraction in rats by decreasing fibrosis and inflammation, JACC: basic to translational","volume":"1","author":"Gallet","year":"2016","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.bbadis.2023.166979_bb0030","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1177\/15353702211035058","article-title":"Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction","volume":"246","author":"Chang","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166979_bb0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ejhf.960","article-title":"Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)","volume":"20","author":"Trippel","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166979_bb0040","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166979_bb0045","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2023.166979_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Aspects Med."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166979_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166979_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd.2016.89","article-title":"Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease","volume":"15","author":"Gourdie","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2023.166979_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166979_bb0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/ijms21030970","article-title":"The diabetic cardiac fibroblast: mechanisms underlying phenotype and function","volume":"21","author":"Levick","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166979_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.carpath.2014.03.004","article-title":"Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and type 2 diabetic donors","volume":"23","author":"Sedgwick","year":"2014","journal-title":"Cardiovasc. Pathol."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166979_bb0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.lfs.2013.01.003","article-title":"Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts","volume":"92","author":"Fowlkes","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2023.166979_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","article-title":"Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get With The Guidelines\u2013Heart Failure registry","volume":"182","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0090","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review","volume":"73","author":"McHugh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2023.166979_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2021.06.013","article-title":"FNDC5\/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin \u03b1V\/\u03b25-AKT signaling and reduction of oxidative\/nitrosative stress","volume":"160","author":"Lin","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"18","key":"10.1016\/j.bbadis.2023.166979_bb0100","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.jmb.2018.06.030","article-title":"Mechanistic insights into recognitions of ubiquitin and myosin VI by autophagy receptor TAX1BP1","volume":"430","author":"Hu","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166979_bb0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BCJ20160556","article-title":"NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes","volume":"474","author":"Val-Blasco","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166979_bb0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.omtn.2021.10.013","article-title":"Diverging targets mediate the pathological role of miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis","volume":"26","author":"Zeng","year":"2021","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ajpath.2021.01.016","article-title":"Sustained inhibition of NF-\u03baB activity mitigates retinal vasculopathy in diabetes","volume":"191","author":"Homme","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166979_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/JOE-19-0058","article-title":"Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes","volume":"242","author":"Wu","year":"2019","journal-title":"J. Endocrinol."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166979_bb0125","first-page":"H934","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0130","doi-asserted-by":"crossref","first-page":"10553","DOI":"10.1038\/s41598-021-89989-5","article-title":"AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis","volume":"11","author":"Francisco","year":"2021","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.bbadis.2023.166979_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128722","article-title":"Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart","volume":"4","author":"Khalil","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005155","article-title":"Coronary artery disease associated transcription factor TCF21 regulates smooth muscle precursor cells that contribute to the fibrous cap","volume":"11","author":"Nurnberg","year":"2015","journal-title":"PLoS Genet."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166979_bb0145","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1242\/dev.079970","article-title":"The bHLH transcription factor Tcf21 is needed for lineage-specific EMT of cardiac fibroblast progenitors","volume":"139","author":"Acharya","year":"2012","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.bbadis.2023.166979_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18632\/aging.100655","article-title":"Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease","volume":"6","author":"Tonne","year":"2014","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166979_bb0160","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/mt.2015.78","article-title":"Cardiac AAV9 gene delivery strategies in adult canines: assessment by long-term serial SPECT imaging of sodium iodide symporter expression","volume":"23","author":"Moulay","year":"2015","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Sumanth","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2023.166979_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2014.01.013","article-title":"Fibroblast-mediated pathways in cardiac hypertrophy","volume":"70","author":"Fujiu","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/cvr\/cvp180","article-title":"Liver X receptors are negative regulators of cardiac hypertrophy by suppressing NF-kappaB signaling","volume":"84","author":"Wu","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166979_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jcp.24142","article-title":"Retinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-\u03baB signaling pathway","volume":"228","author":"Nizamutdinova","year":"2013","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166979_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14728222.2021.1849145","article-title":"Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function","volume":"25","author":"Patel","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbadis.2023.166979_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106357","article-title":"Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: in vitro and in vivo activity and mechanisms of action","volume":"182","author":"Yang","year":"2022","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.bbadis.2023.166979_bb0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"30","key":"10.1016\/j.bbadis.2023.166979_bb0200","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: from mechanisms to therapies","volume":"39","author":"Lam","year":"2018","journal-title":"Eur. Heart J."},{"issue":"40","key":"10.1016\/j.bbadis.2023.166979_bb0205","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/eurheartj\/ehz117","article-title":"Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction","volume":"40","author":"Friebel","year":"2019","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166979_bb0210","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","article-title":"Inhibition of the cardiac fibroblast\u2013enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction","volume":"121","author":"Piccoli","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0220","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2011-3002","article-title":"Effect of alipogene tiparvovec (AAV1-LPLS447X) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients","volume":"97","author":"Carpentier","year":"2012","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166979_bb0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10097","key":"10.1016\/j.bbadis.2023.166979_bb0230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomized, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2023.166979_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","article-title":"Chemokines in myocardial infarction","volume":"14","author":"Chen","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.bbadis.2023.166979_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","article-title":"NF-kappaB signaling pathways in neurological inflammation: a mini review","volume":"8","author":"Shih","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166979_bb0245","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1096\/fj.201801513R","article-title":"Critical role of IL-1\u03b1 in IL-1\u03b2\u2013induced inflammatory responses: cooperation with NF-\u03baBp65 in transcriptional regulation","volume":"33","author":"Singh","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2023.166979_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1476-9255-7-59","article-title":"Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-\u03baB-dependent transcription of TNF-\u03b1 and MCP-1\/CCL2 genes by preventing RelA from binding its cognate sites on DNA","volume":"7","author":"Oyegunwa","year":"2010","journal-title":"J. Inflamm."},{"issue":"5 Pt A","key":"10.1016\/j.bbadis.2023.166979_bb0255","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbadis.2018.02.012","article-title":"TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy","volume":"1864","author":"Xiao","year":"2018","journal-title":"BBA-Molecular Basis of Disease"},{"key":"10.1016\/j.bbadis.2023.166979_bb0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","article-title":"An update on the multifaceted roles of STAT3 in the heart","volume":"6","author":"Harhous","year":"2019","journal-title":"Frontiers in Cardiovascular Medicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923003459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923003459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:03:56Z","timestamp":1738436636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923003459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0925443923003459"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166979","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166979"}}